FDA Advisory Committee Recommends Approval Of Forest Laboratories’ Ceftaroline Fosamil For The Treatment Of Community …

FDA Advisory Committee Recommends Approval Of Forest Laboratories’ Ceftaroline Fosamil For The Treatment Of Community …
Forest Laboratories, Inc. (NYSE: FRX) announced that the U.S. Food and Drug Administration’s (FDA) Anti-Infective Drugs Advisory Committee voted 21 – 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 – 0 in favor of approval for complicated skin and skin structure infections (cSSSI)…

Read more on Medical News Today

Tagged with: Advisory • Approval • Ceftaroline • Committee • Community • Forest • Fosamil • Laboratories • Recommends • treatment

Filed under: Skin Care

Like this post? Subscribe to my RSS feed and get loads more!